These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 6324556)

  • 1. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome.
    Sakamoto K; Freed HJ; Purtilo DT
    J Immunol; 1980 Aug; 125(2):921-5. PubMed ID: 6248598
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; DeFlorio D; Hutt LM; Bhawan J; Yang JP; Otto R; Edwards W
    N Engl J Med; 1977 Nov; 297(20):1077-80. PubMed ID: 198660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus and human lymphoproliferative disorders.
    Schnipper LE
    Prog Hematol; 1981; 12():275-97. PubMed ID: 6280236
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 11. The spectrum of Epstein-Barr virus disease.
    O'Dell JR
    Nebr Med J; 1981 Dec; 66(12):275-8. PubMed ID: 6283398
    [No Abstract]   [Full Text] [Related]  

  • 12. Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.
    Purtilo DT
    Semin Oncol; 1977 Sep; 4(3):335-43. PubMed ID: 21454
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT
    Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT
    Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
    [No Abstract]   [Full Text] [Related]  

  • 17. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
    Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and heterophile antibodies in infectious mononucleosis.
    Gotlieb-Stematsky T; Vonsover A; Modan M
    Isr J Med Sci; 1974 Jul; 10(7):731-7. PubMed ID: 4368690
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EB virus, immunodeficiency, bone marrow aplasia, malignant mononucleosis and sex-linked lymphoproliferative B syndrome (XLP)].
    Mathé G
    Biomed Pharmacother; 1983; 37(6):249-50. PubMed ID: 6608379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.